 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0051 |
14542-12-2 |
2-Hydroxymethylthiazole |
|
| A1-0121 |
N/A |
1-Cbz-3-Methylaminoazetidine |
|
| A1-0153 |
912763-14-5 |
1-N-CBZ-2-Phenylpiperazine |
|
| A1-6236 |
2217-41-6 |
5-Aminotetralin |
|
| AS-0226 |
33630-94-3 |
3-Amino-6-hydroxypyridine |
|
| AS-0244 |
2150-43-8 |
Methyl 3,4-dihydroxybenzoate |
|
| AS-0694 |
139-85-5 |
Protocatechualdehyde |
|
| AS-2166 |
32316-92-0 |
2-Naphthaleneboronic acid |
|
| AS-2215 |
4920-80-3 |
3-METHOXY-2-NITROBENZOIC ACID |
|
| AS-2690 |
49561-96-8 |
4-(TRIFLUOROMETHOXY)PHENYLACETONITRILE |
|
| AS-3623 |
60323-96-8 |
2-CHLORO-5-METHYL-4-NITROPYRIDINE-N-OXIDE |
|
| AS-3755 |
167145-13-3 |
2-[2-(3-Methoxyphenyl)ethyl]phenol |
|
| AS-4410 |
14804-31-0 |
4-BROMO-2-METHYLANISOLE |
|
| AS-5006 |
52090-56-9 |
3-AMINO-6-METHOXY-2-PICOLINE |
|
| AS-6303 |
160129-45-3 |
7-CHLORO-1,2,3,4-TETRAHYDRO-BENZO[B]AZEPIN-5-ONE |
|
| AS-8590 |
597554-03-5 |
10-(2-Naphthyl)anthracene-9-boronic acid |
|
| AS-8641 |
23814-14-4 |
2-OXO-2,3-DIHYDRO-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID |
|
| BTC-001074 |
40914-11-2 |
2-Chloro-N-(cyclohexylmethyl)acetamide |
|
| JR02-H079 |
1854943-73-9 |
3-(3-Methoxy-4-nitrophenyl)-9-methyl-3,9-diazaspiro[5.5]undecane |
|
| JR02-H085 |
61070-99-3 |
Pyridazine-3,6-diamine |
|
| JR6-L1865 |
2096998-29-5 |
tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole-1-carboxylate |
|
| JR6-L2066 |
151911-33-0 |
Benzenepropanoic acid, ß-amino-4-fluoro-, (ßS)- |
|
| JR6-L2068 |
479074-63-0 |
Benzenepropanoic acid, ß-amino-4-bromo-, (ßR)- |
|
| JR6-L2122 |
612532-16-8 |
Benzenepropanoic acid, ß-amino-2,4-difluoro-, (ßS)- |
|
| JR6-L2189 |
918864-97-8 |
Benzenepropanoic acid, ß-amino-2-fluoro-, methyl ester, (ßR)- |
|
| JR6-L2495 |
1250225-28-5 |
Benzenemethanol, 3-chloro-4-hydroxy-a-(trifluoromethyl)- |
|
| JR6-L2589 |
87694-53-9 |
Carbamic acid, N-[(1S)-2-(methoxymethylamino)-2-oxo-1-(phenylmethyl)ethyl]-, 1,1-dimethylethyl ester |
|
| JR6-L2807 |
1018446-60-0 |
1H-Pyrazole-3-carboxylic acid, 5-hydroxy-, methyl ester |
|
| JR6-L3477 |
215433-50-4 |
[1,1'-Binaphthalene]-2,2'-diol, 3,3'-bis(2,6-dimethylphenyl)-, (1R)- |
|
| JR6-L3573 |
952490-31-2 |
Acetic acid, 2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (1E)-1,3-butadien-1-yl ester |
|
| JR6-L3807 |
1414976-25-2 |
Cyclopentanemethanamine, 2-(dimethoxymethyl)-, (1R,2R)- |
|
| JR6-L3809 |
1414976-23-0 |
Cyclopentane, 1-(dimethoxymethyl)-2-(nitromethyl)-, (1R,2R)- |
|
| JR6-L3887 |
951008-56-3 |
2-Pyrrolidinemethanol, a,a-bis([1,1':3',1''-terphenyl]-5'-yl)-, (2S)- |
|
| JR6-L4024 |
124730-56-9 |
4H-Pyrrolo[3,2,1-ij]quinoline-1-carboxylic acid, 5,6-dihydro- |
|
| JR6-L4032 |
1283096-73-0 |
Oxirane, 2-[(2,4,5-trifluorophenyl)methyl]- |
|
| JR6-L4207 |
1212391-70-2 |
1-Piperidinecarboxylic acid, 4-oxo-2-(phenylmethyl)-, 1,1-dimethylethyl ester, (2R)- |
|
| JR6-L4208 |
1120351-38-3 |
1-Piperidinecarboxylic acid, 4-oxo-2-(phenylmethyl)-, phenylmethyl ester, (2R)- |
|
| JR6-L4317 |
666719-85-3 |
Hexadecanoic acid, 16-mercapto-, 2,5-dioxo-1-pyrrolidinyl ester |
|
| JR6-L4322 |
887407-52-5 |
N-Succinimidyloxycarbonylpentadecyl Methanethiosulfonate |
|
| JR6-L4773 |
1154415-61-8 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 8-(cyclopentylamino)-3,4-dihydro-6-methyl-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4775 |
921760-66-9 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-4-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester |
|
| JR6-L4971 |
1260760-60-8 |
Cyclopropanecarbonitrile, 1-(2,4-difluorophenyl)- |
|
| JR6-L5194 |
345660-50-6 |
1-Piperidinecarboxylic acid, 4-(6-fluoro-1,2-benzisoxazol-3-yl)-, 1,1-dimethylethyl ester |
|
| JR6-L5429 |
126410-46-6 |
Carbamic acid, [1-ethenyl-2-[4-(phenylmethoxy)phenyl]ethyl]-, 1,1-dimethylethyl ester, (S)- (9CI) |
|
| JR6-L5647 |
72486-09-0 |
3-Butyn-1-ol, 1-methanesulfonate |
|
| JR6-L5818 |
1219603-30-1 |
3,4-Morpholinedicarboxylic acid, 2-methyl-, 4-(9H-fluoren-9-ylmethyl) 3-methyl ester, (2R,3S)- |
|
| JR6-L6027 |
856972-52-6 |
2,4-Pyrimidinediamine, 6-(1-naphthalenyl)-N4,5-bis(phenylmethyl)- |
|
| JR6-L6191 |
883523-22-6 |
4-Pyridinecarboxamide, N-[4-[[(3,4-dimethyl-5-isoxazolyl)amino]sulfonyl]phenyl]-2-(4-fluorophenyl)- |
|
| JR6-L6277 |
101981-96-8 |
1-Propanone, 1-(11,12-dihydrodibenz[b,f]azocin-5(6H)-yl)-3-(4-morpholinyl)- |
|
| JR6-L6284 |
1099464-23-9 |
Benzamide, N-[4-[(11,12-dihydrodibenz[b,f]azocin-5(6H)-yl)carbonyl]phenyl]-2-methoxy- |
|
| JR6-L6431 |
880652-89-1 |
Quinoline, 4-[1-[1-(triphenylmethyl)-1H-imidazol-4-yl]ethenyl]- |
|
| JR6-L6517 |
1384278-48-1 |
1,2,3-Benzothiadiazole-7-carboxylic acid, 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ester |
|
| JR6-L6545 |
1368043-28-0 |
2-Benzothiazolamine, 6,7-dimethyl-4-nitro- |
|
| JR6-L6548 |
176392-39-5 |
2-Benzothiazolamine, 6,7-dichloro-4-nitro- |
|
| JR6-L6717 |
61229-03-6 |
Oxirane, 2-pentyl-, (2S)- |
|
| JR6-L6888 |
4749-37-5 |
METHYL (2E)-3-NITROPROP-2-ENOATE |
|
| JR6-L7365 |
113534-13-7 |
2-Propanol, 1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (2S)- |
|
| JR6-L7544 |
1335534-83-2 |
4-Pyridineethanamine, 2-chloro-3-fluoro-a-methyl-, (aS)- |
|
| JR6-L7591 |
1336171-35-7 |
2-Pyridineethanamine, 5-chloro-a-methyl-, (aR)- |
|
| JR6-L7599 |
1336010-17-3 |
2-Pyridineethanamine, 6-chloro-a-methyl-, (aR)- |
|
| JR6-L7607 |
1335823-17-0 |
2-Pyridineethanamine, 3-fluoro-a-methyl-, (aR)- |
|
| JR6-L7842 |
129215-12-9 |
Oxirane, 2-(3-nitrophenyl)-, (2R)- |
|
| JR6-L7934 |
1344603-87-7 |
2H-Indol-2-one, 3-amino-5-fluoro-1,3-dihydro-3-methyl-, (3S)- |
|
| JR6-L8043 |
1217630-38-0 |
Pyrrolidine, 2-(2,5-difluorophenyl)-, (2S)- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|